glutathione leukemia ROS-dependent therapeutic agents for treatment. The mechanism Sgc8 aptamer targeted glutathione-responsive nanoassemblies
Sgc8 aptamer targeted glutathione responsive nanoassemblies containing Ara C prodrug for the treatment of acute lymphoblastic leukemia Nanoscale (RSC Publishing) Mechanisms of Drug Resistance in Acute Myeloid Leukemia Oncology Nurse Advisor iFSP1 is a Selective FSP1 Inhibitor Glutathione Independently Network of Cancer Research Fueling the Fire: How Glutamine Metabolism Sustains Leukemia Growth and Resistance
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


